SlideShare a Scribd company logo
1 of 2
Download to read offline
January 2015 100
Quarterly Performance (INR Million)
FY14 FY15 FY14 FY15E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Total Volumes (nos) 21,721 23,110 18,393 26,048 19,981 25,371 24,462 32,249 89,337 102,063
Growth % -21.0 -22.6 -18.9 -24.8 -8.0 9.8 33.0 23.8 -22.1 14.2
Realizations ('000) 1,088 1,103 1,062 1,181 1,240 1,268 1,251 1,271 1,113 1,259
% change -0.5 -0.1 1.1 9.7 14.0 15.0 17.8 7.6 2.2 13.1
Net Sales 23,638 25,496 19,532 30,768 24,778 32,176 30,592 40,974 99,434 128,520
Change (%) -21.4 -22.6 -17.9 -17.5 4.8 26.2 56.6 33.2 -20.3 29.3
RM/Sales % 75.5 76.3 79.7 75.3 73.3 73.6 74.0 73.8 76.5 73.7
Staff / sales % 10.9 10.0 12.3 8.0 11.4 9.1 9.3 7.7 10.1 9.1
Oth. Exp./ Sales % 12.6 11.5 13.0 10.7 10.6 10.1 10.4 9.3 11.8 9.9
EBITDA 233 563 -969 1,839 1,161 2,343 1,938 3,757 1,666 9,283
EBITDA Margins (%) 1.0 2.2 -5.0 6.0 4.7 7.3 6.3 9.2 1.7 7.2
Other Income 123 231 154 157 231 257 225 212 665 925
Interest 1,007 1,244 1,153 1,126 1,063 1,007 1,000 1,055 4,529 4,126
Depreciation 952 901 883 1,034 1,033 1,031 1,070 1,096 3,770 4,230
PBT before EO Exp -1,603 -1,351 -2,851 -163 -704 562 93 1,817 -5,969 1,852
EO Exp/(Inc) 65 -438 -923 -3,761 0 -1,090 0 0 -5,057 -1,090
PBT -1,669 -914 -1,928 3,598 -704 1,652 93 1,817 -912 2,941
Effective Tax Rate (%) 15.0 72.6 13.3 -1.0 31.9 27.0 25.0 27.1 132.2 25.0
Rep. PAT -1,418 -251 -1,672 3,634 -479 1,206 70 1,325 294 2,206
Adj. PAT -1,362 -371 -2,473 -127 -479 410 70 1,325 -4,763 1,389
Change (%) -303 -126 188 -151 -65 -211 -103 -1,144 NA -129.2
E: MOSL Estimates
December 2014 Results Preview | Sector: Automobiles
Ashok Leyland
CMP: INR51 Buy
n Expect volumes to grow by 33% YoY (-3.6% QoQ) led by a revival in
demand seen in HCV.
n MHCVs volumes are expected to grow by 60% YoY (-6.1% QoQ) as
business sentiments and economic activity improve.
n Expect realizations to improve by 17.8% YoY (-1.4% QoQ) on better
product mix (higher MHCV share).
n EBITDA margin is expected to be 6.3% (v/s 7.3% in 2QFY15 and 4.7%
in 1QFY15).
n Expect to report PAT of INR70m (v/s a loss of INR1.6b in 3QFY14).
n We lower FY15E/FY16E EPS by 6.6%/3% as we factor for the delay in
discount reductions. Maintain Buy.
Key issues to watch out
Ø Current demand environment and discounting trend, plant and
channel inventory for MHCVs.
Ø Industry growth, market share guidance for MHCVs and LCVs for
FY16.
Ø Pantnagar volume guidance, RM cost outlook and margin
guidance for FY16.
Ø Capex and investment guidance and divestment plans for FY16.
Bloomberg AL IN
Equity Shares (m) 2,845.9
M. Cap. (INR b)/(USD b) 146/2
52-Week Range (INR) 56/15
1,6,12 Rel Perf. (%) 2/32/169
Financial Snapshot (INR Billion)
Y/E March 2014 2015E 2016E 2017E
Sales 99.4 128.5 172.6 223.3
EBITDA 1.7 9.3 17.1 24.7
NP (4.8) 1.1 7.5 13.1
Adj. EPS (1.8) 0.4 2.6 4.6
EPS Gr. (%) NA NA NA NA
BV/Sh. (INR) 16.7 18.7 20.8 24.8
RoE (%) (10.7) 3.1 14.8 20.3
RoCE (%) (1.5) 6.0 13.2 20.2
Payout (%) - - 18.9 10.8
Valuations
P/E (x) (28.7) 93.3 17.1 11.1
P/BV (x) 3.1 2.7 2.5 2.1
EV/EBITDA 105.8 18.5 9.6 6.9
Div. Yield (%) - - 1.0 1.0
Thematic | Sector Capital Goods
7 January 2015 26
Disclosures
This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This
report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to
invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been
furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into
account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable
for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and
investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur.
We are under the process of seeking registration under SEBI (Research Analyst) Regulations, 2014. There are no disciplinary action that have been taken by any regulatory authority impacting equity
research analysis activities.
MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business
relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection
processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that
the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may
interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the
profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from
maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an
officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading
strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with
the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and
its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in
any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its
affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to
hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The
information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt’s interpretation of the
data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not
intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt
and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its
affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of
its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of
merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations.
Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its
contents.
MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of
Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.
Disclosure of Interest Statement Companies where there is interest
§ Analyst ownership of the stock Nil
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or
will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible
for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to
law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions.
For U.K.
This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to
which this document relates is only available to investment professionals and will be engaged in only with such persons.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States.
In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state
laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein
are not available to or intended for U.S. persons.
This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional
investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major
institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as
amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has
entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be
executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer,
MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research
analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors
Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore
to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time.
In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited:
Anosh Koppikar Kadambari Balachandran
Email : anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com
Contact : (+65)68189232 Contact : (+65) 68189233 / 65249115
Office Address : 21 (Suite 31),16 Collyer Quay,Singapore 04931
Motilal Oswal Securities Ltd
Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025
Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com

More Related Content

What's hot

Daily Derivatives Report:29 January 2019
Daily Derivatives Report:29 January 2019Daily Derivatives Report:29 January 2019
Daily Derivatives Report:29 January 2019Axis Direct
 
Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019Axis Direct
 
Daily Derivatives Report:07 March 2019
Daily Derivatives Report:07 March 2019Daily Derivatives Report:07 March 2019
Daily Derivatives Report:07 March 2019Axis Direct
 
Daily Derivatives Report:21 November 2019
Daily Derivatives Report:21 November 2019Daily Derivatives Report:21 November 2019
Daily Derivatives Report:21 November 2019Axis Direct
 
Daily Derivatives Report:06 February 2020
Daily Derivatives Report:06 February 2020Daily Derivatives Report:06 February 2020
Daily Derivatives Report:06 February 2020Axis Direct
 
Daily Derivatives Report:29 November 2018
Daily Derivatives Report:29 November 2018Daily Derivatives Report:29 November 2018
Daily Derivatives Report:29 November 2018Axis Direct
 
Daily Equity Report 10 May 2019
Daily Equity Report 10 May 2019Daily Equity Report 10 May 2019
Daily Equity Report 10 May 2019Myra Cheng
 
Daily Derivatives Report:22 March 2019
Daily Derivatives Report:22 March 2019Daily Derivatives Report:22 March 2019
Daily Derivatives Report:22 March 2019Axis Direct
 
Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020Axis Direct
 
Daily Derivatives Report:04 February 2020
Daily Derivatives Report:04 February 2020Daily Derivatives Report:04 February 2020
Daily Derivatives Report:04 February 2020Axis Direct
 
Daily Derivatives Report:29 January 2020
Daily Derivatives Report:29 January 2020Daily Derivatives Report:29 January 2020
Daily Derivatives Report:29 January 2020Axis Direct
 
Daily Derivatives Report:07 May 2019
Daily Derivatives Report:07 May 2019Daily Derivatives Report:07 May 2019
Daily Derivatives Report:07 May 2019Axis Direct
 
Morning tea 01 08-2016
Morning tea 01 08-2016Morning tea 01 08-2016
Morning tea 01 08-2016Choice Equity
 
Daily Derivatives Report:29 May 2019
Daily Derivatives Report:29 May 2019Daily Derivatives Report:29 May 2019
Daily Derivatives Report:29 May 2019Axis Direct
 
Daily Derivatives Report:09 January 2020
Daily Derivatives Report:09 January 2020Daily Derivatives Report:09 January 2020
Daily Derivatives Report:09 January 2020Axis Direct
 
Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020Axis Direct
 
Daily Derivatives Report:05 February 2020
Daily Derivatives Report:05 February 2020Daily Derivatives Report:05 February 2020
Daily Derivatives Report:05 February 2020Axis Direct
 
Daily Derivatives Report:06 November 2019
Daily Derivatives Report:06 November 2019Daily Derivatives Report:06 November 2019
Daily Derivatives Report:06 November 2019Axis Direct
 
Daily Derivatives Report:03 January 2019
Daily Derivatives Report:03 January 2019Daily Derivatives Report:03 January 2019
Daily Derivatives Report:03 January 2019Axis Direct
 
Daily Derivatives Report:15 November 2019
Daily Derivatives Report:15 November 2019Daily Derivatives Report:15 November 2019
Daily Derivatives Report:15 November 2019Axis Direct
 

What's hot (20)

Daily Derivatives Report:29 January 2019
Daily Derivatives Report:29 January 2019Daily Derivatives Report:29 January 2019
Daily Derivatives Report:29 January 2019
 
Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019
 
Daily Derivatives Report:07 March 2019
Daily Derivatives Report:07 March 2019Daily Derivatives Report:07 March 2019
Daily Derivatives Report:07 March 2019
 
Daily Derivatives Report:21 November 2019
Daily Derivatives Report:21 November 2019Daily Derivatives Report:21 November 2019
Daily Derivatives Report:21 November 2019
 
Daily Derivatives Report:06 February 2020
Daily Derivatives Report:06 February 2020Daily Derivatives Report:06 February 2020
Daily Derivatives Report:06 February 2020
 
Daily Derivatives Report:29 November 2018
Daily Derivatives Report:29 November 2018Daily Derivatives Report:29 November 2018
Daily Derivatives Report:29 November 2018
 
Daily Equity Report 10 May 2019
Daily Equity Report 10 May 2019Daily Equity Report 10 May 2019
Daily Equity Report 10 May 2019
 
Daily Derivatives Report:22 March 2019
Daily Derivatives Report:22 March 2019Daily Derivatives Report:22 March 2019
Daily Derivatives Report:22 March 2019
 
Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020
 
Daily Derivatives Report:04 February 2020
Daily Derivatives Report:04 February 2020Daily Derivatives Report:04 February 2020
Daily Derivatives Report:04 February 2020
 
Daily Derivatives Report:29 January 2020
Daily Derivatives Report:29 January 2020Daily Derivatives Report:29 January 2020
Daily Derivatives Report:29 January 2020
 
Daily Derivatives Report:07 May 2019
Daily Derivatives Report:07 May 2019Daily Derivatives Report:07 May 2019
Daily Derivatives Report:07 May 2019
 
Morning tea 01 08-2016
Morning tea 01 08-2016Morning tea 01 08-2016
Morning tea 01 08-2016
 
Daily Derivatives Report:29 May 2019
Daily Derivatives Report:29 May 2019Daily Derivatives Report:29 May 2019
Daily Derivatives Report:29 May 2019
 
Daily Derivatives Report:09 January 2020
Daily Derivatives Report:09 January 2020Daily Derivatives Report:09 January 2020
Daily Derivatives Report:09 January 2020
 
Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020
 
Daily Derivatives Report:05 February 2020
Daily Derivatives Report:05 February 2020Daily Derivatives Report:05 February 2020
Daily Derivatives Report:05 February 2020
 
Daily Derivatives Report:06 November 2019
Daily Derivatives Report:06 November 2019Daily Derivatives Report:06 November 2019
Daily Derivatives Report:06 November 2019
 
Daily Derivatives Report:03 January 2019
Daily Derivatives Report:03 January 2019Daily Derivatives Report:03 January 2019
Daily Derivatives Report:03 January 2019
 
Daily Derivatives Report:15 November 2019
Daily Derivatives Report:15 November 2019Daily Derivatives Report:15 November 2019
Daily Derivatives Report:15 November 2019
 

Similar to Ashok Leyland Q3FY15 Preview: Buy at a CMP of Rs51

Daily Derivatives Report:29 March 2019
Daily Derivatives Report:29 March 2019Daily Derivatives Report:29 March 2019
Daily Derivatives Report:29 March 2019Axis Direct
 
Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020Axis Direct
 
Daily Derivatives Report:13 November 2018
Daily Derivatives Report:13 November 2018Daily Derivatives Report:13 November 2018
Daily Derivatives Report:13 November 2018Axis Direct
 
Bulls Eye October 2010
Bulls  Eye  October 2010Bulls  Eye  October 2010
Bulls Eye October 2010chetsons
 
Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019Axis Direct
 
Daily Derivatives Report:14 December 2018
Daily Derivatives Report:14 December 2018Daily Derivatives Report:14 December 2018
Daily Derivatives Report:14 December 2018Axis Direct
 
Daily Derivatives Report:14 November 2018
Daily Derivatives Report:14 November 2018Daily Derivatives Report:14 November 2018
Daily Derivatives Report:14 November 2018Axis Direct
 
Daily Derivatives Report:28 December 2018
Daily Derivatives Report:28 December 2018Daily Derivatives Report:28 December 2018
Daily Derivatives Report:28 December 2018Axis Direct
 
Daily Derivatives Report:31 October 2018
Daily Derivatives Report:31 October 2018Daily Derivatives Report:31 October 2018
Daily Derivatives Report:31 October 2018Axis Direct
 
Daily Derivatives Report:18 December 2018
Daily Derivatives Report:18 December 2018Daily Derivatives Report:18 December 2018
Daily Derivatives Report:18 December 2018Axis Direct
 
Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019Axis Direct
 
Daily Derivatives Report:26 March 2019
Daily Derivatives Report:26 March 2019Daily Derivatives Report:26 March 2019
Daily Derivatives Report:26 March 2019Axis Direct
 
Daily Derivatives Report:25 October 2018
Daily Derivatives Report:25 October 2018Daily Derivatives Report:25 October 2018
Daily Derivatives Report:25 October 2018Axis Direct
 
Daily Derivatives Report:13 December 2018
Daily Derivatives Report:13 December 2018Daily Derivatives Report:13 December 2018
Daily Derivatives Report:13 December 2018Axis Direct
 
Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019Axis Direct
 
Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018Axis Direct
 
Daily Technical Report:30 August 2019
Daily Technical Report:30 August 2019Daily Technical Report:30 August 2019
Daily Technical Report:30 August 2019Axis Direct
 
Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019Axis Direct
 
Daily Technical Report:28 June 2019
Daily Technical Report:28 June 2019Daily Technical Report:28 June 2019
Daily Technical Report:28 June 2019Axis Direct
 
Daily Derivatives Report:21 November 2018
Daily Derivatives Report:21 November 2018Daily Derivatives Report:21 November 2018
Daily Derivatives Report:21 November 2018Axis Direct
 

Similar to Ashok Leyland Q3FY15 Preview: Buy at a CMP of Rs51 (20)

Daily Derivatives Report:29 March 2019
Daily Derivatives Report:29 March 2019Daily Derivatives Report:29 March 2019
Daily Derivatives Report:29 March 2019
 
Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020
 
Daily Derivatives Report:13 November 2018
Daily Derivatives Report:13 November 2018Daily Derivatives Report:13 November 2018
Daily Derivatives Report:13 November 2018
 
Bulls Eye October 2010
Bulls  Eye  October 2010Bulls  Eye  October 2010
Bulls Eye October 2010
 
Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019
 
Daily Derivatives Report:14 December 2018
Daily Derivatives Report:14 December 2018Daily Derivatives Report:14 December 2018
Daily Derivatives Report:14 December 2018
 
Daily Derivatives Report:14 November 2018
Daily Derivatives Report:14 November 2018Daily Derivatives Report:14 November 2018
Daily Derivatives Report:14 November 2018
 
Daily Derivatives Report:28 December 2018
Daily Derivatives Report:28 December 2018Daily Derivatives Report:28 December 2018
Daily Derivatives Report:28 December 2018
 
Daily Derivatives Report:31 October 2018
Daily Derivatives Report:31 October 2018Daily Derivatives Report:31 October 2018
Daily Derivatives Report:31 October 2018
 
Daily Derivatives Report:18 December 2018
Daily Derivatives Report:18 December 2018Daily Derivatives Report:18 December 2018
Daily Derivatives Report:18 December 2018
 
Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019
 
Daily Derivatives Report:26 March 2019
Daily Derivatives Report:26 March 2019Daily Derivatives Report:26 March 2019
Daily Derivatives Report:26 March 2019
 
Daily Derivatives Report:25 October 2018
Daily Derivatives Report:25 October 2018Daily Derivatives Report:25 October 2018
Daily Derivatives Report:25 October 2018
 
Daily Derivatives Report:13 December 2018
Daily Derivatives Report:13 December 2018Daily Derivatives Report:13 December 2018
Daily Derivatives Report:13 December 2018
 
Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019
 
Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018
 
Daily Technical Report:30 August 2019
Daily Technical Report:30 August 2019Daily Technical Report:30 August 2019
Daily Technical Report:30 August 2019
 
Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019
 
Daily Technical Report:28 June 2019
Daily Technical Report:28 June 2019Daily Technical Report:28 June 2019
Daily Technical Report:28 June 2019
 
Daily Derivatives Report:21 November 2018
Daily Derivatives Report:21 November 2018Daily Derivatives Report:21 November 2018
Daily Derivatives Report:21 November 2018
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15IndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 

Recently uploaded

Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...
Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...
Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...ssifa0344
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikCall Girls in Nagpur High Profile
 
The Economic History of the U.S. Lecture 30.pdf
The Economic History of the U.S. Lecture 30.pdfThe Economic History of the U.S. Lecture 30.pdf
The Economic History of the U.S. Lecture 30.pdfGale Pooley
 
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Delhi Call girls
 
Bladex Earnings Call Presentation 1Q2024
Bladex Earnings Call Presentation 1Q2024Bladex Earnings Call Presentation 1Q2024
Bladex Earnings Call Presentation 1Q2024Bladex
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesMarketing847413
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfAdnet Communications
 
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...Call Girls in Nagpur High Profile
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfGale Pooley
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptxFinTech Belgium
 
20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdfAdnet Communications
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...shivangimorya083
 
Quarter 4- Module 3 Principles of Marketing
Quarter 4- Module 3 Principles of MarketingQuarter 4- Module 3 Principles of Marketing
Quarter 4- Module 3 Principles of MarketingMaristelaRamos12
 
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Pooja Nehwal
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptxFinTech Belgium
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designsegoetzinger
 

Recently uploaded (20)

Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...
Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...
Solution Manual for Financial Accounting, 11th Edition by Robert Libby, Patri...
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
 
The Economic History of the U.S. Lecture 30.pdf
The Economic History of the U.S. Lecture 30.pdfThe Economic History of the U.S. Lecture 30.pdf
The Economic History of the U.S. Lecture 30.pdf
 
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
 
Bladex Earnings Call Presentation 1Q2024
Bladex Earnings Call Presentation 1Q2024Bladex Earnings Call Presentation 1Q2024
Bladex Earnings Call Presentation 1Q2024
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast Slides
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdf
 
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
 
Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdf
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx
 
20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
 
Quarter 4- Module 3 Principles of Marketing
Quarter 4- Module 3 Principles of MarketingQuarter 4- Module 3 Principles of Marketing
Quarter 4- Module 3 Principles of Marketing
 
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designs
 

Ashok Leyland Q3FY15 Preview: Buy at a CMP of Rs51

  • 1. January 2015 100 Quarterly Performance (INR Million) FY14 FY15 FY14 FY15E 1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE Total Volumes (nos) 21,721 23,110 18,393 26,048 19,981 25,371 24,462 32,249 89,337 102,063 Growth % -21.0 -22.6 -18.9 -24.8 -8.0 9.8 33.0 23.8 -22.1 14.2 Realizations ('000) 1,088 1,103 1,062 1,181 1,240 1,268 1,251 1,271 1,113 1,259 % change -0.5 -0.1 1.1 9.7 14.0 15.0 17.8 7.6 2.2 13.1 Net Sales 23,638 25,496 19,532 30,768 24,778 32,176 30,592 40,974 99,434 128,520 Change (%) -21.4 -22.6 -17.9 -17.5 4.8 26.2 56.6 33.2 -20.3 29.3 RM/Sales % 75.5 76.3 79.7 75.3 73.3 73.6 74.0 73.8 76.5 73.7 Staff / sales % 10.9 10.0 12.3 8.0 11.4 9.1 9.3 7.7 10.1 9.1 Oth. Exp./ Sales % 12.6 11.5 13.0 10.7 10.6 10.1 10.4 9.3 11.8 9.9 EBITDA 233 563 -969 1,839 1,161 2,343 1,938 3,757 1,666 9,283 EBITDA Margins (%) 1.0 2.2 -5.0 6.0 4.7 7.3 6.3 9.2 1.7 7.2 Other Income 123 231 154 157 231 257 225 212 665 925 Interest 1,007 1,244 1,153 1,126 1,063 1,007 1,000 1,055 4,529 4,126 Depreciation 952 901 883 1,034 1,033 1,031 1,070 1,096 3,770 4,230 PBT before EO Exp -1,603 -1,351 -2,851 -163 -704 562 93 1,817 -5,969 1,852 EO Exp/(Inc) 65 -438 -923 -3,761 0 -1,090 0 0 -5,057 -1,090 PBT -1,669 -914 -1,928 3,598 -704 1,652 93 1,817 -912 2,941 Effective Tax Rate (%) 15.0 72.6 13.3 -1.0 31.9 27.0 25.0 27.1 132.2 25.0 Rep. PAT -1,418 -251 -1,672 3,634 -479 1,206 70 1,325 294 2,206 Adj. PAT -1,362 -371 -2,473 -127 -479 410 70 1,325 -4,763 1,389 Change (%) -303 -126 188 -151 -65 -211 -103 -1,144 NA -129.2 E: MOSL Estimates December 2014 Results Preview | Sector: Automobiles Ashok Leyland CMP: INR51 Buy n Expect volumes to grow by 33% YoY (-3.6% QoQ) led by a revival in demand seen in HCV. n MHCVs volumes are expected to grow by 60% YoY (-6.1% QoQ) as business sentiments and economic activity improve. n Expect realizations to improve by 17.8% YoY (-1.4% QoQ) on better product mix (higher MHCV share). n EBITDA margin is expected to be 6.3% (v/s 7.3% in 2QFY15 and 4.7% in 1QFY15). n Expect to report PAT of INR70m (v/s a loss of INR1.6b in 3QFY14). n We lower FY15E/FY16E EPS by 6.6%/3% as we factor for the delay in discount reductions. Maintain Buy. Key issues to watch out Ø Current demand environment and discounting trend, plant and channel inventory for MHCVs. Ø Industry growth, market share guidance for MHCVs and LCVs for FY16. Ø Pantnagar volume guidance, RM cost outlook and margin guidance for FY16. Ø Capex and investment guidance and divestment plans for FY16. Bloomberg AL IN Equity Shares (m) 2,845.9 M. Cap. (INR b)/(USD b) 146/2 52-Week Range (INR) 56/15 1,6,12 Rel Perf. (%) 2/32/169 Financial Snapshot (INR Billion) Y/E March 2014 2015E 2016E 2017E Sales 99.4 128.5 172.6 223.3 EBITDA 1.7 9.3 17.1 24.7 NP (4.8) 1.1 7.5 13.1 Adj. EPS (1.8) 0.4 2.6 4.6 EPS Gr. (%) NA NA NA NA BV/Sh. (INR) 16.7 18.7 20.8 24.8 RoE (%) (10.7) 3.1 14.8 20.3 RoCE (%) (1.5) 6.0 13.2 20.2 Payout (%) - - 18.9 10.8 Valuations P/E (x) (28.7) 93.3 17.1 11.1 P/BV (x) 3.1 2.7 2.5 2.1 EV/EBITDA 105.8 18.5 9.6 6.9 Div. Yield (%) - - 1.0 1.0
  • 2. Thematic | Sector Capital Goods 7 January 2015 26 Disclosures This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. We are under the process of seeking registration under SEBI (Research Analyst) Regulations, 2014. There are no disciplinary action that have been taken by any regulatory authority impacting equity research analysis activities. MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt’s interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement Companies where there is interest § Analyst ownership of the stock Nil Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Anosh Koppikar Kadambari Balachandran Email : anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact : (+65)68189232 Contact : (+65) 68189233 / 65249115 Office Address : 21 (Suite 31),16 Collyer Quay,Singapore 04931 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com